Solta

Solta Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel repair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system, a treatment to improve skin texture and help prevent the signs of aging skin. The company also provides Thermage CPT system that provides non-invasive treatment options using radiofrequency energy for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; a collection of surgical and non-surgical body shaping products; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the treatment of mild-to-moderate inflammatory acne, including pustular acne. Its customers consist primarily of dermatologists, plastic surgeons, general and family practitioners, gynecologists, ophthalmologists, and others. The company sells its products through direct sales force and independent distributors; and CLARO device through retail and associated retailer’s Websites, television retail networks, and owned Website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California.